Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone - Inserm - Institut national de la santé et de la recherche médicale
Journal Articles Lancet Oncology Year : 2024

Dates and versions

inserm-04714848 , version 1 (30-09-2024)

Licence

Copyright

Identifiers

Cite

F Anthony Greco, Chris Labaki, Elie Rassy. Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone. Lancet Oncology, 2024, 25 (8), pp.955-956. ⟨10.1016/S1470-2045(24)00344-9⟩. ⟨inserm-04714848⟩
34 View
2 Download

Altmetric

Share

More